Dr. Edward A. Stadtmauer, MD

Dr. Stadtmauer practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Stadtmauer's NPI, 1457394744, was assigned on June 14, 2006. Dr. Stadtmauer graduated from Perelman School of Med at the University of Pennsylvania in 1983. Dr. Stadtmauer holds Pennsylvania license MD034788E.

Dr. Stadtmauer's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Stadtmauer's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Stadtmauer is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Stadtmauer to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stadtmauer practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Stadtmauer's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Stadtmauer is licensed in Pennsylvania.

CMS data shows 1,379 Medicare services from Dr. Stadtmauer across 4 procedure codes in 2024, for 379 Medicare patients. Medicare paid $140,793 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 379 Medicare patients who saw Dr. Stadtmauer in 2024. The largest group is 65 to 74, with 204 patients. 74% of them have high cholesterol, and 70% have high blood pressure. 3% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stadtmauer's median patient age at 73, with 49% women.

In 2024, Dr. Stadtmauer wrote 886 Medicare Part D claims for 153 patients. 66% of them were for generic drugs. CMS names the drug for 690 of them, across 16 drugs with 11 or more claims each, at $7,380,540 in total drug cost. In 2023, CMS named 631 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Stadtmauer for performance year 2024, reported individually. Dr. Stadtmauer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stadtmauer as offering telehealth.

Dmand AI links 104 papers to Dr. Stadtmauer, published from 2015 to 2025. 2022 was the busiest year, with 12. The most frequent topics are Multiple Myeloma, Hematopoietic Stem Cell Transplantation and Transplantation, Autologous. Dr. Stadtmauer has published most often in Bone Marrow Transplant. Dr. Stadtmauer's most frequent co-authors are Noelle Virginia Frey, MD, Elizabeth O. Hexner, MD and Alison W. Loren, MD.

Dmand AI links Dr. Stadtmauer to 1 clinical trial. Conditions studied include Multiple Myeloma and Blood Protein Disorders. Open Payments lists research payments to Dr. Stadtmauer that name 1 trial.

CMS Open Payments shows 144 general payments to Dr. Stadtmauer from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Sanofi and Genzyme US Companies paid the most, $32,617. It also lists 3 research payments totaling $914 from 2017 to 2018, naming 1 clinical trial.

Dr. Stadtmauer graduated from Perelman School of Med at the University of Pennsylvania in 1983.